FDA Inspection 1002329 — Changzhou Jintan Qianyao Pharmaceutical Raw Materials
The FDA completed an inspection of Changzhou Jintan Qianyao Pharmaceutical Raw Materials on February 17, 2017 in Jintan. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 17, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jintan (China)